
IASLC Lung Cancer Considered Drug Development and Targeted Therapies
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses targeted therapies, what they are, and how they have changed our approach to treating not just lung cancer, but cancers in gen...
5 Sep 202350min

I want to be an oncologist: Where to start?
In this epidose of Lung Cancer Considered, Dr. Narjust Florez leads a discussion on the journey to an oncology fellowship. Medical training is long, full of sacrifices and student debt for many. For...
29 Aug 202343min

Lung Cancer Care in Mandarin: EGFR in China - From Testing to Treating
Lung Cancer Care in Mandarin: EGFR in China - From Testing to Treating by IASLC
25 Aug 202356min

Artificial Intelligence And Lung Cancer
Artificial intelligence is one of the most significant trends in most parts of society. Increasingly, oncologists and lung cancer researchers are including AI in research and patient care. In this e...
15 Aug 202340min

LCC in Greek: Treating Lung Cancer in Greece
Greece ranks third in mortality in Europe from lung cancer, surpassed by Hungary and Serbia. In this episode of Lung Cancer Considered, host Dr. Giannis Mountzios, Director of the 4th Oncology Depart...
8 Aug 20231h 1min

IASLC Hot Topic in Basic and Translational Science Meeting Preview
This episode of Lung Cancer Considered previews the upcoming IASLC Hot Topic in Basic and Translational Science Meeting on Resistance to Immunotherapy in NSCLC. Joining host Dr. Stephen Liu are: Gue...
4 Aug 202321min

Updated IASLC - Virtual Tumor Board On SCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the management of small-cell lung cancer using a virtual tumor board format. SCLC is an aggressive subtype of lung cancer and ...
1 Aug 202349min

iMig Meeting Highlights
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discuss some of the highlights from iMig 2023 – the meeting of the International Mesothelioma Interest Group, an IASLC-endorsed meeting...
18 Jul 202332min


















